scispace - formally typeset
C

Chris J.L.M. Meijer

Researcher at VU University Amsterdam

Publications -  745
Citations -  83366

Chris J.L.M. Meijer is an academic researcher from VU University Amsterdam. The author has contributed to research in topics: Cervical cancer & Cervical intraepithelial neoplasia. The author has an hindex of 128, co-authored 733 publications receiving 78705 citations. Previous affiliations of Chris J.L.M. Meijer include VU University Medical Center & Academic Center for Dentistry Amsterdam.

Papers
More filters
Journal ArticleDOI

Role of Epstein-Barr virus DNA load monitoring in prevention and early detection of post-transplant lymphoproliferative disease

TL;DR: This review focuses on the clinical utility of EBV DNA load monitoring in the peripheral blood of transplant recipients using PCR and discusses the currently most-widely used techniques and their value and limitations in predicting and diagnosing PTLD.
Journal ArticleDOI

Repression of MAL tumour suppressor activity by promoter methylation during cervical carcinogenesis

TL;DR: MAL gene silencing by promoter methylation is a frequent and biologically essential event in HPV‐induced cervical carcinogenesis and may provide a valuable diagnostic tool to improve the detection of CIN3, SCC, and AdCA.
Journal ArticleDOI

HPV DNA testing in population-based cervical screening (VUSA-Screen study): results and implications.

TL;DR: Primary hrHPV screening with cytology triage in women aged ⩾30 years is an effective way to stratify women on CIN3+ risk and seems a feasible alternative to cytological screening, however repeat cytology after 1 year is however necessary before returning women to routine screening.
Journal ArticleDOI

Cutting Edge: Polycomb Gene Expression Patterns Reflect Distinct B Cell Differentiation Stages in Human Germinal Centers

TL;DR: It is shown that human Pc-G expression patterns correlate with different B cell differentiation stages and that they reflect germinal center (GC) architecture, and a role for P c-G proteins in GC development is suggested.
Journal ArticleDOI

Methylation Analysis of the FAM19A4 Gene in Cervical Scrapes Is Highly Efficient in Detecting Cervical Carcinomas and Advanced CIN2/3 Lesions

TL;DR: FAM19A4 is an attractive triage marker for hrHPV-positive women, with a high reassurance for the detection of cervical carcinoma and advanced CIN2/3 lesions.